Implantable Cardioverter Defibrillators Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Implantable Cardioverter Defibrillators Market to 2027- Global Analysis and Forecasts By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Defibrillator (CRT-D)), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and others) and Geography

Report Code: TIPMD00002563 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
An implantable cardioverter-defibrillator (ICD) is an implanted device inside the body, able to perform cardioversion, defibrillation, and (in modern versions) pacing of the heart. The device is therefore capable of correcting most life-threatening cardiac arrhythmias. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia.

The market of implantable cardioverter defibrillators is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing incidences of cardiovascular disorders, increasing demand for implantable cardioverter defibrillator from emerging countries of Asia-Pacific and the Middle-East as cardiovascular disorders are increasing and awareness about the disease also increases in these countries, increasing number of training and awareness programs across the globe for implantable cardioverter defibrillators.

The "Global Implantable Cardioverter Defibrillators Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The implantable cardioverter defibrillators market report aims to provide an overview of global Implantable Cardioverter Defibrillators market with detailed market segmentation by product, and end user. The global implantable cardioverter defibrillators market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global implantable cardioverter defibrillators market is segmented on the basis of product, and end user. The product segment includes, transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. The transvenous implantable cardioverter defibrillators segment is further segmented into biventricular implantable cardioverter defibrillators, single chambered, and dual chambered. Based on end user, the implantable cardioverter defibrillators market is segmented as, hospitals, specialty clinics, ambulatory surgical centers and others.

The implantable cardioverter defibrillators market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global implantable cardioverter defibrillators market based on product, and end user. It also provides market size and forecast till 2027 for overall implantable cardioverter defibrillators market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The implantable cardioverter defibrillators market report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the implantable cardioverter defibrillators market in the coming years, owing to factors such as, increase in prevalence of cardiac disorders, arrhythmias, and sudden cardiac arrest; rise in demand for long-lasting battery life for ICD devices; improvement in healthcare infrastructure; and growth in geriatric population. However, Asia-Pacific is anticipated to register the highest growth rate owing to the large pool of patient population.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The implantable cardioverter defibrillators market report also includes the profiles of key implantable cardioverter defibrillators manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., ZOLL Medical Corporation, Physio-Control Inc., Nihon Kohden Corporation, Pacetronix.com, EBR Systems Inc., and MEDICO S.p.A. among others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Implantable Cardioverter Defibrillators Market - By Product
3.2.2. Implantable Cardioverter Defibrillators Market - By End User
3.2.3. Implantable Cardioverter Defibrillators Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
5.2. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.3.1. Overview
6.3.2. Transvenous Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Biventricular Implantable Cardioverter Defibrillators Market
6.3.3.1. Overview
6.3.3.2. Biventricular Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Single Chambered Market
6.3.4.1. Overview
6.3.4.2. Single Chambered Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Dual Chambered Market
6.3.5.1. Overview
6.3.5.2. Dual Chambered Market Revenue Forecasts and Analysis (US$ Mn)
6.4. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.4.1. Overview
6.4.2. Subcutaneous Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis (US$ Mn)
7. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 -BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS MARKET
7.3.1. Overview
7.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
7.4. SPECIALTY CLINICS MARKET
7.4.1. Overview
7.4.2. Specialty Clinics Market Revenue Forecasts and Analysis (US$ Mn)
7.5. AMBULATORY SURGICAL CENTERS MARKET
7.5.1. Overview
7.5.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
8.2. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
8.3.1. North America Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.5. US MARKET OVERVIEW
8.5.1. US Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.5.1.1. US Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.5.2. US Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.6. CANADA MARKET OVERVIEW
8.6.1. Canada Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.6.1.1. Canada Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. Canada Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. MEXICO MARKET OVERVIEW
8.7.1. Mexico Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.7.1.1. Mexico Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Mexico Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
9.2. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.3.1. Europe Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.1.1. France Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. France Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.1.1. Germany Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Germany Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.1.1. UK Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. UK Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
10.2. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.3.1. Asia Pacific Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.1.1. China Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. China Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.1.1. India Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By type (US$ Mn)
10.7.2. India Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.1.1. Japan Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. Japan Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.3.1. Middle East And Africa (MEA) Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.1.1. South Africa Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. South Africa Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.1.1. Saudi Arabia Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2. Saudi Arabia Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.1.1. UAE Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2. UAE Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.3.1. South and Central America Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.1.1. Brazil Transvenous Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2. Brazil Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions
14. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, KEY COMPANY PROFILES
14.1. MEDTRONIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BOSTON SCIENTIFIC CORPORATION
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. KONINKLIJKE PHILIPS N.V.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ZOLL MEDICAL CORPORATION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. PHYSIO-CONTROL INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. NIHON KOHDEN CORPORATION
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. PACETRONIX.COM
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. EBR SYSTEMS INC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. MEDICO S.P.A.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. Medtronic
2. Abbott
3. Boston Scientific Corporation
4. Koninklijke Philips N.V.
5. ZOLL Medical Corporation
6. Physio-Control Inc
7. NIHON KOHDEN CORPORATION
8. Pacetronix.com
9. EBR Systems Inc
10. MEDICO S.p.A.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book